1,3-dipropyl-8-cyclopentylxanthine has been researched along with Nasopharyngeal Carcinoma in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pan, S | 1 |
Zhang, X | 1 |
Guo, Y | 1 |
Li, Y | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Nasopharyngeal Carcinoma
Article | Year |
---|---|
DPCPX induces Bim-dependent apoptosis in nasopharyngeal carcinoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, Nude; Nasopharyngeal C | 2022 |